New Leaf Venture Partners
New Leaf Venture Partners (NLVP) is a venture investment firm focused exclusively on healthcare technology. The firm invests across biopharmaceuticals, information convergence (healthcare IT/data), life science tools and select medical devices, partnering with management teams from company creation through public and private markets. NLVP combines capital with domain expertise, operational involvement and an advisory network to support strategy, team building, regulatory planning, market access and scaling.
New Leaf Venture Partners
New York, New York, United States, North America
Services
Equity investment (early to growth stages)
Direct venture and growth-stage equity investments across healthcare technology, from company creation through IPO and public markets.
Strategic guidance and board-level involvement
Active strategic engagement including investment team involvement, board participation and assistance with company strategy and product/clinical development plans.
Operational support and team building
Hands-on assistance to help portfolio companies build teams, refine operations, and commercialize products.
Network and advisory access
Access to an advisory network including CIOs, health system leaders, entrepreneurs and industry executives to inform strategy, partnerships and market access.
Portfolio management across private and public markets
Ongoing portfolio management support including assistance with public-market transitions and exit processes.
Equity investment (early to growth stages)
Direct venture and growth-stage equity investments across healthcare technology, from company creation through IPO and public markets.
Strategic guidance and board-level involvement
Active strategic engagement including investment team involvement, board participation and assistance with company strategy and product/clinical development plans.
Operational support and team building
Hands-on assistance to help portfolio companies build teams, refine operations, and commercialize products.
Network and advisory access
Access to an advisory network including CIOs, health system leaders, entrepreneurs and industry executives to inform strategy, partnerships and market access.
Portfolio management across private and public markets
Ongoing portfolio management support including assistance with public-market transitions and exit processes.
Portfolio
Developing treatments for autoimmune disorders and rare cancers. Based in Newton, MA.
#Biopharmaceuticals
Develops therapies for muscular dystrophies and cardiac conditions. Public: NASDAQ: EWTX.
#Biopharmaceuticals
Software and services for connected medical devices with regulatory and privacy compliance. Based in San Jose, CA.
#Information Convergence
Applies AI to identify factors leading to coronary disease. Based in New York, NY.
#Information Convergence
Developing therapies for systemic mastocytosis and gastrointestinal stromal tumors (GIST). Public: NASDAQ: COGT. Based in Cambridge, MA.
#Biopharmaceuticals
Wireless ultrasound system for fluid resuscitation and management. Based in Ontario, Canada.
#Medical Devices
Developing treatments for autoimmune disorders and rare cancers. Based in Newton, MA.
#Biopharmaceuticals
Develops therapies for muscular dystrophies and cardiac conditions. Public: NASDAQ: EWTX.
#Biopharmaceuticals
Software and services for connected medical devices with regulatory and privacy compliance. Based in San Jose, CA.
#Information Convergence
Applies AI to identify factors leading to coronary disease. Based in New York, NY.
#Information Convergence
Developing therapies for systemic mastocytosis and gastrointestinal stromal tumors (GIST). Public: NASDAQ: COGT. Based in Cambridge, MA.
#Biopharmaceuticals
Wireless ultrasound system for fluid resuscitation and management. Based in Ontario, Canada.
#Medical Devices